Issue 1,636: June 8, 2022
 
Top Stories
 
Immunize.org Pages and Handouts
 
Vaccine Information Statements
 
Featured Resources
 
Notable Publications
 
Upcoming Events
 
Top Stories

CDC releases new VIS for smallpox/monkeypox vaccine and updated VIS for rabies vaccine

Immunize.org posted two new VISs, published by CDC.

    

Related Links


Immunize.org updates “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools”

Immunize.org offers a two-page job aid, Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools, to help you keep up with changes to COVID-19 vaccine guidance and resources. The checklist includes the most recent revision dates of CDC’s primary COVID-19 vaccination websites, as well as print-ready PDF documents from CDC and FDA. Each date is hyperlinked to the original document or web page. Immunize.org updates this list at least monthly, prominently indicating when it was last updated at the top of the page.

The most recent checklist update, as of June 2, 2022, includes the addition of CDC's At-A-Glance: COVID-19 Vaccination Schedules. We encourage COVID-19 vaccination providers to review this checklist monthly to be sure your practices stay up to date. 
 


Related Links


Immunize.org releases updated print-ready recommendation summaries for adults and for children and adolescents

On June 6, 2022, Immunize.org released 2022 updates to its popular print-ready resources titled Summary of Recommendations for Child/Teen Immunization (Age birth through 18) and Summary of Recommendations for Adult Immunization (Age 19 years and older). Edits were made to be consistent with the 2022 recommended schedules published by CDC.



Related Links

Back to top


Vaccinate Your Family releases new animated video explaining how vaccines work

Vaccinate Your Family released a new animated video How Do Vaccines Work? Available in English and Spanish, this 1-minute 26-second clip explains how vaccines work by comparing them to a sports playbook that helps the home team (your immune system) prepare for the visiting virus (an infection). You don't show up to the big game unprepared, and your immune system shouldn't either. 


Who needs another tie? Show your dad how much you care; be sure he’s protected from vaccine-preventable diseases!

Men’s Health Week is celebrated each year as the week leading up to and including Father’s Day. The purpose of Men’s Health Week is to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys. 

This Father's Day, encourage the dads and other men in your life to be vaccinated against serious diseases. Download Immunize.org's Summary of Recommendations for Adult Immunization to determine which vaccines they need. 

Think pneumococcal, shingles, hepatitis B, Tdap, COVID-19, influenza (before Thanksgiving Day), and more.


Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 559 institutions, including one new honoree. Seven previously honored institutions qualify for sustained honors.

Immunize.org is pleased to announce acceptance of one new institution into its Hepatitis B Birth Dose Honor Roll, for a total of 559 honorees. The birthing institution is listed below with its reported hepatitis B birth dose coverage rate in parentheses.

  • Riverview Health, Noblesville, IN (94%)

Several institutions are recognized for qualifying for an additional year: 

HealthAlliance Hospital, Kingston, NY 90% 2 years
Bellevue Woman’s Center, Niskayuna, NY 94% 3 years
Elmhurst Hospital, Elmhurst, IL 91% 3 years
CarolinaEast Medical Center, New Bern, NC 92% 5 years
Lincoln Memorial Hospital, Lincoln, IL 93% 5 years
Georgetown Community Hospital, Georgetown, KY 96% 7 years
Oneida Health, Oneida, NY 94% 7 years

The Honor Roll now includes 559 birthing institutions from 44 states, the District of Columbia, Puerto Rico, Guam, Saipan, and a U.S. military base in England.

The Honor Roll is a key part of Immunize.org’s major initiative urging the nation’s hospitals to Give Birth to the End of Hep B. Hospitals and birthing centers are recognized for attaining high coverage rates of hepatitis B vaccination at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online.

Qualifications: To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90% or greater, over a 12-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection before hospital discharge.

Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IZ Express’s 54,000+ readers.

Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.

Related Immunize.org Resources


Influenza activity continues to increase in some areas 

Influenza Surveillance
For week 21, ending on May 28, CDC's Weekly U.S. Influenza Surveillance Report, FluView summary reports that seasonal influenza activity continues to increase in some parts of the country. The levels of outpatient visits due to acute respiratory illness remained stable compared to last week.

CDC continues to recommend influenza vaccination as long as influenza viruses are circulating. Vaccination may still prevent serious outcomes in people who are vaccinated but get sick.



VaccineFinder at “Vaccines.gov”
If you don’t provide influenza vaccine at your site, please strongly recommend vaccination and refer people to sites that do vaccinate. “Vaccines.gov” is powered by VaccineFinder, a service of Boston Children’s Hospital, to help people find influenza, COVID-19, and other vaccines for any age group. 

Related Links

Back to top


Spotlight! Immunize.org’s “Clinic Tools: Administering Vaccines” main page provides tools from authoritative sources.

Immunize.org's Clinic Tools: Administering Vaccines main page is a collection of resources from Immunize.org, CDC, and other organizations. To find it, select the "Clinic Tools" tab in the middle of the blue banner atop every Immunize.org web page and then select "Administering Vaccines."

In the left-hand column of the page, you will find Immunize.org's educational materials such as:

  • Administering Vaccines: Dose, Route, Site, and Needle Size
  • Don’t Be Guilty of These Preventable Errors in Vaccine Administration
  • Skills Checklist for Vaccine Administration; and related resources
The right-hand column of the page features resources from CDC, including:
  • Links to vaccine administration guidelines
  • “General Best Practice Guidelines for Immunization”
  • The Epidemiology and Prevention of Vaccine-Preventable Diseases ("The Pink Book")



Visit the Clinic Tools: Administering Vaccines main page on Immunize.org.

Related Links


Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.


Immunize.org Pages and Handouts

Immunize.org posts seven translations of its parent handout “Vaccinations for Preteens and Teens”  

Immunize.org recently updated its popular parent handout titled Vaccinations for Preteens and Teens to add COVID-19 vaccine and to indicate HPV vaccine may be started at age 9 years.



Translations of this popular handout are now available in seven languages.

Related Links


Immunize.org posts seven translations of its parent handout “When Do Children and Teens Need Vaccinations?”

Immunize.org recently updated its popular parent handout titled When Do Children and Teens Need Vaccinations? to add COVID-19 vaccine and to indicate HPV vaccine may be started at age 9 years.



Translations of this popular handout are now available in seven languages.

Related Links


Vaccine Information Statements

Immunize.org posts Ukrainian translations of six Vaccine Information Statements

Immunize.org posted Ukrainian translations of Vaccine Information Statements (VISs) issued by CDC on August 6 and October 15, 2021. These translations were generously donated by the Immunization Program of the Oregon Health Authority.

All translations are available in print-ready PDF format. 

VIS translations in Ukrainian:

Related Links


Immunize.org updates "You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!" and "Dates of Current Vaccine Information Statements (VISs)”

Immunize.org updated two key documents to help you manage your inventory of VISs.

The revisions reflect changes to the current VIS dates of the Smallpox/Monkeypox Vaccine VIS, and the Rabies Vaccine VIS, as detailed in a separate story.
        


Related Links


Featured Resources

Immunization coalitions collaborate to launch “We the People Vax” website; use their social media messages and resources to promote vaccination in your community

In 2019, to promote the patriotism of vaccinating to keep our communities healthy, We the People Vax was formed by four state immunization coalitions—Arizona, California, Indiana, and Wisconsin. This effort has reached thousands of people via social media campaigns that coincide with holidays throughout the year.

As we approach the Fourth of July holiday, We the People Vax launched their new website www.wethepeoplevax.org. This website will allow you to download current campaigns or become a member or partner. Please help to spread awareness of the campaign by following them on social media and liking, sharing, and retweeting their messages.



Related Links


Reminder: CDC updates clinical considerations for COVID-19 vaccines, including guidance on second booster doses and vaccination after SARS-CoV-2 infection

CDC updated their Interim Clinical Considerations addressing use of COVID-19 vaccines currently approved or authorized in the United States on May 20. This guidance provides important details on use of COVID-19 vaccines. All healthcare professionals administering or counseling patients on COVID-19 vaccination should review all changes on the web page.

CDC summarized the May 20 changes as follows:

  • New guidance for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children age 5–11 years
  • Updated guidance that the following people should receive a second COVID-19 booster dose:
    • People age 12 years and older who are moderately or severely immunocompromised
    • People age 50 years and older
  • Updated guidance for people who are moderately or severely immunocompromised and are treated with B-cell-depleting therapies
  • Clarification of COVID-19 vaccination guidance for multisystem inflammatory syndrome in children (MIS-C) and adults (MIS-A)
  • Updated guidance for primary series vaccination after SARS-CoV-2 infection

View the CDC’s Interim Clinical Considerations web page addressing use of COVID-19 vaccines currently approved or authorized in the United States.

Related Links


Reminder: Immunize.org releases Ask the Experts Special Edition on adult hepatitis B vaccination and COVID-19 vaccines

On June 2, Immunize.org published a Special Edition of IZ Express, Ask the Experts: Immunize.org Answers Questions about Adult Hepatitis B Vaccination and COVID-19 Vaccines. This issue includes nine Q&As about hepatitis B vaccination based on the new ACIP recommendations for vaccination of all adults through age 59 years, published May 26, 2022. It also features six questions from Immunize.org’s Ask the Experts COVID-19 vaccination Q&As, updated on May 24, 2022. 

View the Special Edition of IZ Express, Ask the Experts: Immunize.org Answers Questions about Adult Hepatitis B Vaccination and COVID-19 Vaccines for answers to the following questions.

Adult Hepatitis B Vaccination Questions

  • Which adults should receive hepatitis B vaccine (HepB)?
  • Where can I locate CDC's recommendations for HepB vaccination?
  • Which HepB products can be given to adult patients?
  • Please provide information about the newest product option for adult HepB vaccination, PreHevbrio.
  • Please explain the HepB vaccination schedule options available for the different HepB products.
  • Can Heplisav-B or PreHevbrio be used to complete a vaccination series started with Engerix-B or Recombivax HB?
  • Is it safe for a person at risk of hepatitis B to be vaccinated during pregnancy?
  • I'm a nurse who received the HepB series more than 10 years ago and had a positive follow-up titer (at least 10 mIU/mL). At present, my titer is negative (less than 10 mIU/mL). What should I do now?
  • Who should not receive HepB?

COVID-19 Vaccination Questions

  • How does CDC define being “up to date” on COVID-19 vaccination?
  • What are the recommendations for COVID-19 vaccination of children younger than 12 years?
  • What is the recommended interval between dose 1 and dose 2 of mRNA vaccines for people age 5 years and older and why did it change?
  • What is the recommended first and second booster dose schedule for recipients of an mRNA COVID-19 vaccine primary series?
  • What is the recommended booster dose schedule for recipients of the Janssen COVID-19 Vaccine (Johnson & Johnson)?
  • Should people who have had COVID-19 illness be vaccinated?

Back to top


Notable Publications

CDC publishes “Monkeypox Outbreak—Nine States, May 2022” as an MMWR Early Release

CDC published Monkeypox Outbreak—Nine States, May 2022 on June 3 as an MMWR Early Release. Portions of the document appear below. 

CDC is tracking multiple reported U.S. monkeypox cases, and monitoring cases in persons in countries without endemic monkeypox and with no known travel links to an endemic area; current epidemiology suggests person-to-person community spread....

CDC also facilitated the availability of vaccine PEP [post-exposure prophylaxis] to contacts with high-risk exposures (e.g., unprotected contact with the skin or mucous membranes, lesion, or body fluids of a patient) or certain intermediate risk exposures (e.g., being within ≤6 ft of an unmasked patient for ≥3 hours without wearing, at a minimum, a surgical mask). PEP is not recommended for low or uncertain risk (e.g., health care providers entering a patient’s room without eye protection).


Access the MMWR article in HTML or PDF.

Related Link


CDC publishes “Influenza A(H3N2) Outbreak following a School Event—Los Angeles, California, March 2022” in MMWR

CDC published Influenza A(H3N2) Outbreak following a School Event—Los Angeles, California, March 2022 on June 3 in MMWR. A media summary appears below. 

This influenza A(H3N2) virus outbreak among attendees of an off-campus school banquet in LA County, Los Angeles shows that flu viruses can spread easily among people during large social gatherings and have the potential to cause outbreaks of respiratory disease as COVID-19 preventive measures are being lifted across the country....Out of a total 177 students and seven teachers who attended an off-campus school banquet in LA County, Los Angeles, 72 (41%) students reported having the flu after the event. Because of the high attack rate, the school was temporarily closed to in-person attendance. Flu activity in this LA County community had more than tripled in the weeks leading up to the outbreak, and local mandates to reduce COVID-19 (i.e., face masks and physical distancing) were lifted in the community and at the school in the weeks leading up to the outbreak. Medical providers should consider the possibility of influenza in patients with respiratory disease, given ongoing late-season influenza activity in the United States.

Access the MMWR article in HTML or PDF.

Related Link


Upcoming Events

Virtual: Upcoming FDA Advisory Committee meetings will discuss COVID-19 mRNA vaccines for young children on June 14–15

FDA will convene its Vaccines and Related Biological Products Advisory Committee (VRBPAC) several times in June to discuss use of COVID-19 vaccine topics. Of special interest to IZ Express readers are their meetings on June 14 and 15.

June 14: To discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents age 6 years through 17 years. 

June 15: To discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children age 6 months through 5 years, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children age 6 months through 4 years.

Briefing materials for these meetings will be posted to VRBPAC web pages specific for each meeting a day or two beforehand.

Related Link


Virtual: Watch June 17–18 ACIP meeting

CDC will convene its Advisory Committee on Immunization Practices (ACIP) on June 17 from 10:00 a.m.–3:30 p.m. (ET) and June 18, 2022 from 10:00 a.m.–4:00 p.m. (ET).



No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.

Related Links


Virtual: GSK hosts free global event, “Masterclass in Vaccinology 2.0,”
on June 23

GlaxoSmithKline (GSK) will offer a free virtual global event titled Masterclass in Vaccinology 2.0 on June 23. This is an opportunity to better understand the science of vaccinology, with the chance to participate in a live Q&A. Participants may choose the sessions they wish to join.
 
Register today.


For more upcoming events, visit our Calendar of Events.
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles. When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue.

IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.IZ Express DisclaimerISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .